Suzanne R. Thibodeaux

525 total citations
28 papers, 387 citations indexed

About

Suzanne R. Thibodeaux is a scholar working on Oncology, Immunology and Hematology. According to data from OpenAlex, Suzanne R. Thibodeaux has authored 28 papers receiving a total of 387 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 12 papers in Immunology and 8 papers in Hematology. Recurrent topics in Suzanne R. Thibodeaux's work include CAR-T cell therapy research (9 papers), Immune Cell Function and Interaction (8 papers) and Immunotherapy and Immune Responses (5 papers). Suzanne R. Thibodeaux is often cited by papers focused on CAR-T cell therapy research (9 papers), Immune Cell Function and Interaction (8 papers) and Immunotherapy and Immune Responses (5 papers). Suzanne R. Thibodeaux collaborates with scholars based in United States, Poland and India. Suzanne R. Thibodeaux's co-authors include Tyler J. Curiel, Vincent Hurez, Lishi Sun, Tahiro Shin, Sara Ludwig, Carolina B. Livi, Srilakshmi Pandeswara, Kruthi Murthy, Bin Zhang and Benjamin J. Daniel and has published in prestigious journals such as Blood, The Journal of Immunology and Cancer Research.

In The Last Decade

Suzanne R. Thibodeaux

26 papers receiving 382 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Suzanne R. Thibodeaux United States 9 219 171 61 39 34 28 387
Juhi R. Kuchroo United States 7 347 1.6× 232 1.4× 79 1.3× 29 0.7× 19 0.6× 9 466
Diego Bertoli Italy 9 126 0.6× 52 0.3× 48 0.8× 35 0.9× 22 0.6× 24 254
Joseph Mears United States 4 213 1.0× 56 0.3× 105 1.7× 23 0.6× 17 0.5× 5 356
Iwona Kwiecień Poland 13 194 0.9× 141 0.8× 70 1.1× 32 0.8× 43 1.3× 35 371
Jacquelyn M. Lykken United States 6 220 1.0× 78 0.5× 54 0.9× 41 1.1× 13 0.4× 20 351
Nikos E. Papaioannou Greece 7 197 0.9× 141 0.8× 95 1.6× 25 0.6× 15 0.4× 8 364
Tina Nham Canada 8 256 1.2× 140 0.8× 63 1.0× 28 0.7× 11 0.3× 13 336
Fréderic Vély France 5 549 2.5× 250 1.5× 98 1.6× 60 1.5× 10 0.3× 5 654
Cathelijn E.M. Aarts Netherlands 8 279 1.3× 67 0.4× 166 2.7× 47 1.2× 39 1.1× 16 453
Gabriel Brisou France 8 278 1.3× 101 0.6× 129 2.1× 13 0.3× 14 0.4× 20 425

Countries citing papers authored by Suzanne R. Thibodeaux

Since Specialization
Citations

This map shows the geographic impact of Suzanne R. Thibodeaux's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suzanne R. Thibodeaux with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suzanne R. Thibodeaux more than expected).

Fields of papers citing papers by Suzanne R. Thibodeaux

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suzanne R. Thibodeaux. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suzanne R. Thibodeaux. The network helps show where Suzanne R. Thibodeaux may publish in the future.

Co-authorship network of co-authors of Suzanne R. Thibodeaux

This figure shows the co-authorship network connecting the top 25 collaborators of Suzanne R. Thibodeaux. A scholar is included among the top collaborators of Suzanne R. Thibodeaux based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suzanne R. Thibodeaux. Suzanne R. Thibodeaux is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tanhehco, Yvette C., Suzanne R. Thibodeaux, Patricia A. Shi, et al.. (2025). Challenges and limitations of mobilization and stem cell collection for gene therapy of sickle cell disease. Blood Advances. 9(24). 6524–6533.
2.
Mamo, Tewodros, et al.. (2025). Apheresis collection parameters for approved CAR T‐cell products need to be standardized. Transfusion. 65(5). 1021–1025.
3.
4.
Thibodeaux, Suzanne R., Dean W. Coble, Magali J. Fontaine, et al.. (2023). Assessing deviations for HPCs obtained during COVID‐19 (ADHOC): Evaluating impact of the COVID‐19 pandemic on cellular therapy products and processes, the BEST collaborative study. Transfusion. 63(4). 782–790. 1 indexed citations
5.
Liu, Hien, Leon Su, Jeffrey L. Winters, et al.. (2022). Considerations for immune effector cell therapy collections: a white paper from the American Society for Apheresis. Cytotherapy. 24(9). 916–922. 5 indexed citations
6.
Thibodeaux, Suzanne R., Nicole A. Aqui, Yara A. Park, et al.. (2022). Lack of defined apheresis collection criteria in publicly available CAR‐T cell clinical trial descriptions: Comprehensive review of over 600 studies. Journal of Clinical Apheresis. 37(3). 223–236. 10 indexed citations
7.
Thibodeaux, Suzanne R., et al.. (2022). Transfusion support for patients with sickle cell disease. Transfusion and Apheresis Science. 61(5). 103556–103556. 5 indexed citations
8.
Thibodeaux, Suzanne R., Srilakshmi Pandeswara, Vincent Hurez, et al.. (2021). IFNα Augments Clinical Efficacy of Regulatory T-cell Depletion with Denileukin Diftitox in Ovarian Cancer. Clinical Cancer Research. 27(13). 3661–3673. 12 indexed citations
9.
Tang, Mei San & Suzanne R. Thibodeaux. (2021). Infectious Disease Testing to Optimize Safety of Hematopoietic Stem Cell Transplant Products. Clinical Microbiology Newsletter. 43(8). 61–67. 2 indexed citations
10.
Thibodeaux, Suzanne R., David H. McKenna, Zbigniew M. Szczepiorkowski, et al.. (2020). A multicenter evaluation of heterogeneity in cellular therapy processing laboratory procedure times to assess workload capacity. Transfusion. 60(8). 1811–1820. 3 indexed citations
11.
Thibodeaux, Suzanne R., et al.. (2019). More efficient exchange of sickle red blood cells can be achieved by exchanging the densest red blood cells: An ex vivo proof of concept study. Transfusion and Apheresis Science. 58(1). 100–106. 2 indexed citations
12.
Paroder, Monika, Nguyet Le, Huy P. Pham, & Suzanne R. Thibodeaux. (2019). Important aspects of T‐cell collection by apheresis for manufacturing chimeric antigen receptor T cells. 3(1). 6 indexed citations
13.
14.
Thibodeaux, Suzanne R., et al.. (2019). Ensuring safety of the blood supply in the United States: Donor screening, testing, emerging pathogens, and pathogen inactivation. Seminars in Hematology. 56(4). 229–235. 14 indexed citations
15.
Bhoj, Vijay, Suzanne R. Thibodeaux, & Bruce L. Levine. (2016). Novel gene and cellular therapy approaches for treating HIV.. PubMed. 21(116). 283–92. 3 indexed citations
16.
Brumlik, Michael J., Srilakshmi Pandeswara, Sara Ludwig, et al.. (2013). TgMAPK1 is a Toxoplasma gondii MAP kinase that hijacks host MKK3 signals to regulate virulence and interferon-γ-mediated nitric oxide production. Experimental Parasitology. 134(3). 389–399. 13 indexed citations
17.
Hurez, Vincent, Benjamin J. Daniel, Lishi Sun, et al.. (2012). Mitigating Age-Related Immune Dysfunction Heightens the Efficacy of Tumor Immunotherapy in Aged Mice. Cancer Research. 72(8). 2089–2099. 82 indexed citations
18.
Sun, Lishi, Vincent Hurez, Suzanne R. Thibodeaux, et al.. (2012). Aged regulatory T cells protect from autoimmune inflammation despite reduced STAT3 activation and decreased constraint of IL‐17 producing T cells. Aging Cell. 11(3). 509–519. 56 indexed citations
19.
Thibodeaux, Suzanne R. & Tyler J. Curiel. (2011). Immune Therapy for Ovarian Cancer: Promise and Pitfalls. International Reviews of Immunology. 30(2-3). 102–119. 18 indexed citations
20.
Daniel, Benjamin J., Srilakshmi Pandeswara, Michael J. Brumlik, et al.. (2010). A simple method to detect Toxoplasma gondii-specific cytotoxic T cells in vivo. Journal of Immunological Methods. 355(1-2). 86–90. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Juhi R. Kuchroo Breakdown of academic impact, for papers by Diego Bertoli Breakdown of academic impact, for papers by Joseph Mears Breakdown of academic impact, for papers by Iwona Kwiecień Breakdown of academic impact, for papers by Jacquelyn M. Lykken Breakdown of academic impact, for papers by Nikos E. Papaioannou Breakdown of academic impact, for papers by Tina Nham Breakdown of academic impact, for papers by Fréderic Vély Breakdown of academic impact, for papers by Cathelijn E.M. Aarts Breakdown of academic impact, for papers by Gabriel Brisou
Rankless by CCL
2026